FLGT - CIK 0001674930
The table below shows Fulgent Genetics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $23.40M | $117.64M | $87.88M | $67.28M | $58.04M | $65.11M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $69.28M | $71.19M | $77.19M | $71.48M | $57.31M | $56.57M |
| Inventory | $770.00K | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $479.04M |
| $507.37M |
| $428.73M |
| $416.78M |
| $326.54M |
| $399.10M |
| Property, plant & equipment | $116.34M | $111.86M | $110.22M | $107.08M | $106.81M | $93.37M |
| Goodwill | $53.73M | $25.08M | $22.05M | $22.05M | $22.05M | $22.05M |
| Total assets | $1.16B | $1.21B | $1.20B | $1.21B | $1.23B | $1.23B |
| Accounts payable | $21.13M | $18.09M | $18.89M | $18.24M | $19.80M | $19.87M |
| Total current liabilities | $90.13M | $72.43M | $71.33M | $65.92M | $73.99M | $75.75M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $112.22M | $93.81M | $88.20M | $82.97M | $98.86M | $103.39M |
| Retained earnings | $505.13M | $553.37M | $559.98M | $578.94M | $596.36M | $611.00M |
| Total equity | $1.05B | $1.13B | $1.12B | $1.13B | $1.14B | $1.13B |